Stratec SE Ownership

SBS Stock  EUR 28.15  0.40  1.40%   
The market capitalization of Stratec SE is €992.2 Million. Stratec SE maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stratec SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Stratec Stock Ownership Analysis

About 40.0% of the company outstanding shares are owned by corporate insiders. The book value of Stratec SE was at this time reported as 17.69. The company has Price/Earnings To Growth (PEG) ratio of 1.71. Stratec SE last dividend was issued on the 23rd of May 2022. STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany. STRATEC SE operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1217 people. To find out more about Stratec SE contact Marcus Wolfinger at 49 7082 7916 0 or learn more at https://www.stratec.com.

Stratec SE Outstanding Bonds

Stratec SE issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Stratec SE uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Stratec bonds can be classified according to their maturity, which is the date when Stratec SE has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Stratec Stock

Stratec SE financial ratios help investors to determine whether Stratec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stratec with respect to the benefits of owning Stratec SE security.